Cargando…
Critical illness polyneuropathy: incidence and risk factors
Autores principales: | Meyer, B, Unger, A, Nikfardjam, M, Delle Karth, G, Mörtl, D, Wöber, C, Heinz, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092836/ http://dx.doi.org/10.1186/cc4808 |
Ejemplares similares
-
Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004) -
Pro-B-type natriuretic peptide predicts mortality in critically ill patients
por: Meyer, B, et al.
Publicado: (2005) -
Repeated measurements of N-terminal pro-brain natriuretic peptide enable dynamic risk stratification in critically ill patients
por: Meyer, B, et al.
Publicado: (2009) -
CT-pro-endothelin-1 and prognosis in critically ill patients with respiratory failure
por: Meyer, B, et al.
Publicado: (2009) -
Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)